Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Accounts Payables (2016 - 2022)

Edesa Biotech's Accounts Payables history spans 10 years, with the latest figure at $5.6 million for Q2 2022.

  • For Q2 2022, Accounts Payables rose 521.4% year-over-year to $5.6 million; the TTM value through Jun 2022 reached $5.6 million, up 521.4%, while the annual FY2021 figure was $1.4 million, 5.5% down from the prior year.
  • Accounts Payables for Q2 2022 was $5.6 million at Edesa Biotech, up from $3.3 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $5.6 million in Q2 2022 and bottomed at $183820.0 in Q4 2018.
  • The 5-year median for Accounts Payables is $903964.0 (2021), against an average of $1.5 million.
  • The largest annual shift saw Accounts Payables tumbled 68.0% in 2018 before it soared 780.04% in 2021.
  • A 5-year view of Accounts Payables shows it stood at $183820.0 in 2018, then surged by 246.82% to $637531.0 in 2019, then surged by 30.42% to $831450.0 in 2020, then soared by 100.46% to $1.7 million in 2021, then surged by 237.03% to $5.6 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Accounts Payables are $5.6 million (Q2 2022), $3.3 million (Q1 2022), and $1.7 million (Q4 2021).